BCTX
Briacell Therapeutics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$31.32M
P/E Ratio
—
EPS
$-14.42
Beta
1.63
52W High
$60.30
52W Low
$3.60
50-Day MA
$4.16
200-Day MA
$9.42
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Briacell Therapeutics Corp
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-30.63M |
| Operating Margin | 0.00% |
| Return on Equity | -179.20% |
| Return on Assets | -89.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.26 |
| Price-to-Book | 0.96 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.25M |
| Float | $6.41M |
| % Insiders | 0.61% |
| % Institutions | 1.05% |
Data last updated: 4/7/2026